+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Calcium Channel Blocker"

From
From
Ischemia Reperfusion Injury Market Report 2025 - Product Thumbnail Image

Ischemia Reperfusion Injury Market Report 2025

  • Report
  • May 2025
  • 175 Pages
  • Global
From
Angina Market Report 2025 - Product Thumbnail Image

Angina Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
From
Hypercholesterolemia Global Market Report 2025 - Product Thumbnail Image

Hypercholesterolemia Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Voltage Dependent T Type Calcium Channel Blockers Market - Product Thumbnail Image

Voltage Dependent T Type Calcium Channel Blockers Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Hypertrophic Cardiomyopathy- Pipeline Insight, 2025 - Product Thumbnail Image

Hypertrophic Cardiomyopathy- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
Pulmonary Hypertension - Pipeline Insight, 2025 - Product Thumbnail Image

Pulmonary Hypertension - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Atrial Fibrillation- Pipeline Insight, 2025 - Product Thumbnail Image

Atrial Fibrillation- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Aneurysmal Subarachnoid Hemorrhage- Pipeline Insight, 2025 - Product Thumbnail Image

Aneurysmal Subarachnoid Hemorrhage- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Refractory Angina- Pipeline Insight, 2025 - Product Thumbnail Image

Refractory Angina- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Buerger's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Buerger's Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
From
Diabetic Cardiomyopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Cardiomyopathy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
From
From
From
Loading Indicator

Calcium Channel Blockers (CCBs) are a class of drugs used to treat cardiovascular diseases such as hypertension, angina, and arrhythmias. They work by blocking the entry of calcium ions into the cells of the heart and blood vessels, thus reducing the force of contraction of the heart and dilating the blood vessels. This reduces the workload on the heart and lowers blood pressure. CCBs are also used to treat other conditions such as migraine headaches and Raynaud's phenomenon. CCBs are generally well tolerated and have few side effects. Common side effects include dizziness, headache, and swelling of the ankles. They may also interact with other medications, so it is important to discuss all medications with a doctor before taking CCBs. The CCB market is a major component of the cardiovascular drug market. It is a highly competitive market, with many companies offering a variety of CCBs. Some of the major companies in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more